In the evolving landscape of diabetes management, novel therapies like semaglutide and retatrutide are gaining traction. These compounds, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family, offer https://alvinfjdi542901.thekatyblog.com/37393245/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management